Nan Fung Group Holdings
Latest statistics and disclosures from Nan Fung Group Holdings's latest quarterly 13F-HR filing:
- Top 5 stock holdings are OCS, MDGL, ONC, INCY, RYTM, and represent 50.02% of Nan Fung Group Holdings's stock portfolio.
- Added to shares of these 5 stocks: Lb Pharmaceuticals, JOBY, ETHA, RKLB, IBIT.
- Started 5 new stock positions in RKLB, IBIT, ETHA, Lb Pharmaceuticals, JOBY.
- Reduced shares in these 3 stocks: ILMN (-$11M), HRMY (-$9.4M), RXRX.
- Sold out of its position in ILMN.
- Nan Fung Group Holdings was a net seller of stock by $-8.8M.
- Nan Fung Group Holdings has $60M in assets under management (AUM), dropping by -6.02%.
- Central Index Key (CIK): 0001782539
Tip: Access up to 7 years of quarterly data
Positions held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 24 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Oculis Holding Ordinary Shares (OCS) | 15.2 | $9.0M | 515k | 17.58 |
|
|
| Madrigal Pharmaceuticals (MDGL) | 9.1 | $5.4M | 12k | 458.66 |
|
|
| Beone Medicines Sponsored Ads (ONC) | 9.0 | $5.4M | 16k | 340.70 |
|
|
| Incyte Corporation (INCY) | 8.4 | $5.0M | 59k | 84.81 |
|
|
| Rhythm Pharmaceuticals (RYTM) | 8.3 | $5.0M | 49k | 100.99 |
|
|
| Lb Pharmaceuticals Com Shs | 7.9 | $4.7M | NEW | 300k | 15.79 |
|
| Joby Aviation Common Stock (JOBY) | 5.9 | $3.5M | NEW | 217k | 16.14 |
|
| Recursion Pharmaceuticals In Cl A (RXRX) | 4.9 | $2.9M | -10% | 595k | 4.88 |
|
| Ascendis Pharma A/s Sponsored Adr (ASND) | 4.5 | $2.7M | 14k | 198.81 |
|
|
| D Fluidigm Corp Del (LAB) | 4.1 | $2.4M | 1.9M | 1.30 |
|
|
| ACADIA Pharmaceuticals (ACAD) | 3.7 | $2.2M | 103k | 21.34 |
|
|
| Argenx Se Sponsored Adr (ARGX) | 3.5 | $2.1M | 2.8k | 737.56 |
|
|
| Kymera Therapeutics (KYMR) | 2.9 | $1.7M | 31k | 56.60 |
|
|
| Ishares Ethereum Tr SHS (ETHA) | 2.7 | $1.6M | NEW | 51k | 31.51 |
|
| Rocket Lab Corp (RKLB) | 2.4 | $1.4M | NEW | 30k | 47.91 |
|
| Ishares Bitcoin Trust Etf Shs Ben Int (IBIT) | 1.7 | $1.0M | NEW | 16k | 65.00 |
|
| Revolution Medicines (RVMD) | 1.5 | $899k | 19k | 46.70 |
|
|
| Harmony Biosciences Hldgs In (HRMY) | 1.3 | $746k | -92% | 27k | 27.56 |
|
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.9 | $534k | 69k | 7.74 |
|
|
| Bolt Biotherapeutics Com New (BOLT) | 0.5 | $310k | 58k | 5.32 |
|
|
| Entrada Therapeutics (TRDA) | 0.5 | $285k | 49k | 5.80 |
|
|
| Replimune Group (REPL) | 0.4 | $267k | 64k | 4.19 |
|
|
| Rani Therapeutics Hldgs Com Cl A (RANI) | 0.4 | $247k | 494k | 0.50 |
|
|
| Bolt Projs Hldgs Com New (BSLK) | 0.3 | $154k | 41k | 3.78 |
|
Past Filings by Nan Fung Group Holdings
SEC 13F filings are viewable for Nan Fung Group Holdings going back to 2021
- Nan Fung Group Holdings 2025 Q3 filed Nov. 13, 2025
- Nan Fung Group Holdings 2025 Q2 filed Aug. 13, 2025
- Nan Fung Group Holdings 2025 Q1 filed May 14, 2025
- Nan Fung Group Holdings 2024 Q4 filed Feb. 13, 2025
- Nan Fung Group Holdings 2024 Q3 filed Nov. 13, 2024
- Nan Fung Group Holdings 2024 Q2 filed Aug. 13, 2024
- Nan Fung Group Holdings 2024 Q1 filed May 14, 2024
- Nan Fung Group Holdings 2023 Q4 filed Feb. 13, 2024
- Nan Fung Group Holdings 2023 Q3 filed Nov. 13, 2023
- Nan Fung Group Holdings 2023 Q2 filed Aug. 11, 2023
- Nan Fung Group Holdings 2023 Q1 filed May 12, 2023
- Nan Fung Group Holdings 2022 Q4 filed Feb. 13, 2023
- Nan Fung Group Holdings 2022 Q3 filed Nov. 10, 2022
- Nan Fung Group Holdings 2022 Q2 filed Aug. 12, 2022
- Nan Fung Group Holdings 2022 Q1 filed May 13, 2022
- Nan Fung Group Holdings 2021 Q4 filed Feb. 14, 2022